CAMP4 THERAPEUTICS CORPORATION
NASDAQ: CAMP (CAMP4 THERAPEUTICS CORPORATION)
Kemas kini terakhir: 13 jam lalu4.00
0.16 (4.17%)
| Penutupan Terdahulu | 3.84 |
| Jumlah Dagangan | 367,956 |
| Harga / Jualan (P/S) | 43.60 |
| Harga / Buku (P/B) | 9.11 |
| Julat 52 Minggu |
| Margin Operasi (TTM) | -1,526.81% |
| EPS Cair (TTM) | -2.57 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 15.44% |
| Nisbah Semasa (MRQ) | 8.02 |
| Aliran Tunai Operasi (OCF TTM) | -48.70 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -29.66 M |
| Pulangan Atas Aset (ROA TTM) | -71.88% |
| Pulangan Atas Ekuiti (ROE TTM) | -115.06% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | CAMP4 THERAPEUTICS CORPORATION | Bercampur | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -0.5 |
| Purata | -0.83 |
|
Camp4 Therapeutics Corp is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. The company focuses on genetic diseases of the central nervous system and liver. Its pipeline products include CMP-CPS-001 and CMP-SYNGAP. The company operates as a single operating segment, R&D, which engages in the development of a new class of RNA-based therapeutics to treat a broad range of genetic diseases. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 35.41% |
| % Dimiliki oleh Institusi | 56.56% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Harbourvest Partners Llc | 30 Jun 2026 | 1,271,948 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |